Deep Remission Tied to RA Control - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Deep Remission Tied to RA Control

At 5 years, 63% of patients in the CliDR group maintained sustained remission compared with 38% in the non-CliDR group.

  • By

  • Andrea Surnit

  • May 6, 2026

  • 4 min

Share

  • 1

    Patients with rheumatoid arthritis achieving clinical deep remission (CliDR) maintain long-term remission better than those meeting less stringent criteria.

  • 2

    In a study of 145 patients, 63% in the CliDR group maintained sustained remission at 5 years, compared to 38% in the non-CliDR group.

  • 3

    Relapse rates were significantly lower in the CliDR group, with only 12 relapses compared to 70 in the non-CliDR group.

  • 4

    Tapering treatment increased relapse risk 8.5-fold in non-CliDR patients, while the risk was significantly lower in the CliDR group.

  • 5

    The study highlights that deeper remission may offer better prognostic information for treatment tapering decisions in rheumatoid arthritis.

Original Source(s)

Deep Remission Tied to RA Control

  • by Andrea Surnit

  • May 6, 2026

Related Content

PEPITEM Regulates the Synovial Microenvironment During Immune-Mediated Inflammatory Arthritis to Limit Disease

Sex-based differences in hip replacement outcomes

A systematic review of more than 2.3 million patients found that women and men had different patterns of postoperative complications and recovery, with age and implant strategy modifying observed differences.

CAR T Cells Target TNF in Mouse Model of Rheumatoid Arthritis

A single infusion of engineered T cells degraded soluble TNF and produced durable disease control in mice

  • June 30, 2026

  • 3 min